Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications Life Science Investing
Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Life Science Investing
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference Life Science Investing
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results Medical Device Investing
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec in Localized Prostate Cancer Life Science Investing
Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss? Life Science Investing
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 Life Science Investing
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist and Eversense® 365 Life Science Investing
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference 2026 Life Science Investing
